Welcome to the Korean Journal of Physiology & Pharmacology, a pivotal academic platform dedicated to advancing the disciplines of physiology and pharmacology. Published by the esteemed Korean Journal of Physiology & Pharmacology, this journal has been disseminating valuable research findings since its inception in 1997 and continues to be a critical resource for researchers, professionals, and students in South Korea and beyond. With an ISSN of 1226-4512 and E-ISSN of 2093-3827, it offers insights into various aspects of drug action and physiological mechanisms. Although this journal currently does not subscribe to Open Access, it plays a vital role in bridging the gap between experimental and clinical studies, receiving commendations for its quality. In the 2023 Scopus rankings, it is notably positioned in the Q3 quartile for Pharmacology and Q4 for Physiology, reflecting its commitment to excellence. As the journal converges towards its comprehensive coverage in 2024, it remains a cornerstone for those looking to engage deeply with critical developments in these fields.

ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH, published by COGNIZANT COMMUNICATION CORP, is a pivotal journal that delves into the intricate relationship between acupuncture, electro-therapeutics, and their applications in the fields of anesthesiology, pain medicine, and complementary therapies. With an ISSN of 0360-1293 and an E-ISSN of 2167-9010, this esteemed journal has been serving the academic community since 1976 and will continue to publish groundbreaking research until 2024. Despite its current positioning within the Q4 quartiles for both anesthesiology and complementary medicine, ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH remains a valuable platform for disseminating innovative studies that push the boundaries of traditional pain management and neuroscience. Researchers, students, and professionals interested in exploring contemporary therapeutic modalities will find this journal an indispensable resource for understanding the efficacy and applications of acupuncture and electro-therapeutics. With a focus on advancing knowledge in these domains, the journal aims to foster a deeper understanding of integrative approaches to health and wellness.

Frontiers in Pharmacology, published by FRONTIERS MEDIA SA, stands as a leading open-access journal dedicated to advancing the field of pharmacology since its inception in 2010. With its ISSN 1663-9812, the journal is based in Switzerland and maintains a vital role in disseminating innovative research findings that span various disciplines within pharmacology, including pharmacokinetics, toxicology, and pharmacogenetics. In 2023, Frontiers in Pharmacology has achieved an impressive standing within the scientific community, being ranked in the Q1 category for both general and medical pharmacology, highlighting its critical contribution to the field with a Scopus ranking of #41 out of 272 in medical pharmacology and #76 out of 313 in pharmacology, toxicology, and pharmaceutics, placing it in the 75th and 85th percentiles, respectively. Researchers and practitioners benefit from its open-access model, which ensures widespread accessibility to groundbreaking research, fostering collaboration and innovation across the pharmaceutical sciences. With its commitment to excellence, Frontiers in Pharmacology serves as an essential resource for those looking to explore and contribute to the latest advancements in pharmacological research.

AMERICAN JOURNAL OF CHINESE MEDICINE, published by WORLD SCIENTIFIC PUBL CO PTE LTD, is a leading peer-reviewed journal dedicated to the field of complementary and alternative medicine, with a particular focus on the rich traditions and practices of Chinese medicine. Since its establishment, the journal has provided a platform for innovative research and reviews that explore both empirical and theoretical aspects of Chinese medicinal practices, serving an essential role in bridging Eastern and Western medical paradigms. With an impressive impact factor, categorized in the Q1 quartile for both Complementary and Alternative Medicine and Medicine (miscellaneous) in 2023, it ranks as the 4th out of 105 journals in its field according to Scopus, placing it in the 96th percentile. Researchers and students alike will find valuable insights within its pages, as it aims to disseminate high-quality research that contributes to the understanding and application of Chinese medicine in modern healthcare contexts. The journal does not currently offer Open Access options but ensures rigorous academic standards and comprehensive reviews that reflect the evolving landscape of medicine. Located in Singapore, it has emerged as a vital resource for professionals seeking to enhance their knowledge and practice in the dynamic area of complementary health.

Complementary Therapies in Clinical Practice is a premier academic journal published by Elsevier Science Ltd, dedicated to advancing the field of complementary and alternative medicine. With an impressive impact factor placing it in the Q1 category for its field and a Scopus rank of 16 out of 105, it serves as a vital platform for sharing high-quality research and clinical insights. Established in 2005 and continuing through 2024, the journal is committed to disseminating evidence-based practices that enhance patient care and safety. Although it does not offer open access, the journal remains integral to researchers, clinicians, and students striving to integrate complementary therapies within conventional healthcare frameworks. Based in the United Kingdom, the journal not only promotes scholarly discourse but also fosters collaboration across an international community of practitioners dedicated to innovative therapeutic approaches.

New Armenian Medical Journal (ISSN: 1829-0825, E-ISSN: 1829-0825) is a prominent academic publication established by Yerevan State Medical University, dedicated to advancing the field of medicine through high-quality research and scholarly discourse. Located in Armenia, this journal serves as a vital platform for disseminating innovative findings and clinical practices, with a particular focus on the regional healthcare landscape as well as global health issues. While currently categorized in the lower quartile (Q4) of general medicine, it demonstrates a commitment to improving its impact factor and ranking, evidenced by its ongoing publication from 2009 to 2024. The journal embraces a diverse scope that encompasses miscellaneous topics within medical research, catering to the needs of practitioners, researchers, and students alike. Though not an open-access journal, it offers valuable insights and knowledge that contribute meaningfully to the medical community. By participating in this scholarly dialogue, readers can enhance their understanding and foster advancements in the ever-evolving field of medicine.

Avicenna Journal of Phytomedicine, published by Mashhad University of Medical Sciences, is a premier Open Access journal dedicated to advancing the field of phytomedicine. Established in 2011, this journal aims to promote research on the therapeutic potentials of medicinal plants, integrating traditional knowledge with modern pharmacological insights. With an ISSN of 2228-7930 and an E-ISSN of 2228-7949, it has garnered significant attention in the research community, achieving a Q2 ranking in Complementary and Alternative Medicine and a Q3 ranking in Drug Discovery as of 2023. Its Scopus rankings affirm the journal's relevance, with the journal positioned at 37 out of 105 in its category, reflecting a 65th percentile. The Avicenna Journal of Phytomedicine serves as an invaluable resource for researchers, professionals, and students seeking to explore innovative botanical therapies, making it a notable platform for disseminating high-quality research in this burgeoning field.

Jundishapur Journal of Natural Pharmaceutical Products, published by BRIEFLAND in the Netherlands, serves as a pivotal platform for researchers and professionals in the realm of pharmacology and toxicology. With its ISSN 1735-7780 and E-ISSN 2228-7876, the journal has established itself since its inception in 2011, showcasing a commitment to advancing knowledge in natural pharmaceutical products through innovative research. In 2023, it earned a commendable ranking in the Q3 category for Pharmacology, Toxicology, and Pharmaceutics, reflecting its contribution to the field as evidenced by its position in the Scopus rankings. The journal aims to publish high-quality research articles, reviews, and case studies that explore the potential benefits and toxicological aspects of natural products. Although it currently does not offer open access, its rigorous peer-review process ensures that only impactful studies are disseminated, ultimately facilitating a deeper understanding of natural pharmaceutical innovations. For those engaged in this exciting and evolving field, Jundishapur Journal of Natural Pharmaceutical Products is an essential resource that not only expands scholarly discourse but also promotes safe practices in natural product utilization.

Medical Acupuncture is a dedicated peer-reviewed journal that focuses on the intersection of integrative health practices and traditional medicine, particularly emphasizing acupuncture as an evidence-based therapeutic modality. Published by MARY ANN LIEBERT, INC, this journal serves as a pivotal resource for researchers, clinicians, and students in the field of Complementary and Alternative Medicine. With an ISSN of 1933-6586, it has established itself within the academic community, boasting a 2023 Scopus rank of #61 out of 105 in its category, placing it in the 42nd percentile. Although not an open-access journal, it offers a comprehensive platform for exploring the latest developments, clinical applications, and research findings related to acupuncture and its effectiveness in patient care. As it converges years of knowledge from 2008 to 2024, Medical Acupuncture continues to enhance understanding of the therapeutic potential of acupuncture and foster professional discourse in this vital area of health and wellness.

European Journal of Integrative Medicine is a prestigious academic publication under the esteemed Elsevier Science Inc., dedicated to advancing knowledge in the field of Complementary and Alternative Medicine. With an ISSN of 1876-3820 and an E-ISSN of 1876-3839, this journal serves as a pivotal platform for researchers, professionals, and students alike, aiming to explore the integration of holistic practices with conventional medicine. With a Q2 ranking in the 2023 Scopus category for Complementary and Alternative Medicine, and a commendable percentile of 75th, the journal underscores its significance in fostering scholarly discourse and supporting innovative research from 2009 to 2024. The European Journal of Integrative Medicine does not currently offer open access options, encouraging subscription-based access that promotes the quality of published research. This journal is subsequently an essential resource for anyone seeking to deepen their understanding of integrative health approaches and their clinical applications in contemporary medicine.